Austen BioInnovation Institute, Healthcare and Public Health Leaders to Announce New Accountable Care Community Approach to Empower Patients, Improve Approach to Chronic Disease

AKRON, Ohio, Feb. 6, 2012 /PRNewswire-USNewswire/ -- The following is being released today by Austen BioInnovation Institute in Akron:

WHAT: Conference call explaining a new comprehensive approach to community health being developed in Akron, Ohio, with measurable impact on chronic diseases such as diabetes.

The Accountable Care Community initiative involves 60 diverse organizations that emphasize integration and shared responsibility for community health, including health promotion and disease prevention, access to services and care, and healthcare delivery.

WHO: 

Dr. Frank L. Douglas, President and CEO, Austen BioInnovation Institute in Akron

Dr. Janine E. Janosky, Vice President of the Center for Community Health Improvement, Austen BioInnovation Institute in Akron

Dr. C. William Keck, Past President, American Public Health Association; retired City of Akron Director of Health; and Professor Emeritus and former chair of the Northeast Ohio Medical University Department of Behavioral and Community Health Sciences

Dr. Cynthia Capers, Special Assistant to Provost and former dean of College of Nursing, The University of Akron

David R. Zook, Managing Partner, Faegre Baker Daniels' Washington, D.C. office, advisor to private and public sectors on budgetary, legislative and regulatory matters

WHEN: 10 a.m. (EST), Wednesday, Feb. 8

CONTACT: Scott Rainone, ABIA Director of Communications
330‐572‐7581, [email protected]

About Austen BioInnovation Institute in Akron
Based in Akron, Ohio, the Austen BioInnovation Institute in Akron – a unique collaboration of Akron Children's Hospital, Akron General Health System, Northeast Ohio Medical University, Summa Health System, The University of Akron and The John S. and James L. Knight Foundation – is focused on patient‐centered innovation and commercialization at the intersection of biomaterials and medicine. The institute is focused on being a global leader in discovering, developing and commercializing biomaterial solutions for patients with orthopaedic and wound healing problems, nationally distinct in improving health outcomes with a focus on the medically underserved, and recognized for the use of simulation technologies to improve the education of the healthcare team. To learn more about the Austen BioInnovation Institute in Akron, please visit www.abiakron.org.

SOURCE Austen BioInnovation Institute in Akron